WASHINGTON, D.C. -- The Association for Professionals in Infection Control and Epidemiology (APIC) will hold a series of Grand Rounds in various states throughout the country, starting in December and continuing into 2007. The Grand Rounds are designed to educate healthcare professionals and healthcare administrators on how to eliminate the transmission of methicillin-resistant Staphylococcus aureus (MRSA), the antibiotic-resistant superbug impacting millions of patients worldwide.
Over the next six months APICs Grand Rounds: Elimination of MRSA Transmission will be held in Washington, Philadelphia, St. Louis, Dallas, and New York City. The program will feature nationally recognized physicians and infection prevention professionals discussing the consequences of MRSA, an increasingly prevalent and deadly organism in healthcare facilities. More importantly, the panel will highlight successful, systems-wide approaches that have effectively combated the increasingly troublesome infection.
Leading institutions are proving that significant reductions in MRSA can be achieved and sustained through a combination of committed leadership and the application of best practices, said Kathy L. Warye, APICs CEO. The Grand Rounds series is intended to build awareness and accelerate the learning necessary to combat MRSA. In keeping with our zero tolerance position on healthcare-associated infections, this program is intended to clearly demonstrate to clinicians and healthcare administrators how they can create effective strategies for protecting their patients from this deadly infection. By learning how successful healthcare institutions have implemented scientific methodologies, hospitals will be better equipped to introduce effective measures in their own facilities.
The Grand Rounds program, sponsored by BD (Becton, Dickinson and Company), is aimed at both clinicians and healthcare executives faced with the clinical and financial impact of MRSA in their facilities.
BD is proud to sponsor APIC for this educational series to promote best practices in healthcare, with the ultimate goal of eradicating MRSA, said Edward J. Ludwig, chairman, president, and chief executive officer of BD. APIC has demonstrated leadership in driving change in infection prevention and control. BDs support for this effort is central to our commitment to prevent healthcare-associated infections and help all people live healthy lives."
Source: APIC
Â
Â
Â
Â
Â
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.